ROYAL PRIMARY CARE CLAY CROSS — All Prescriptions & Medications — Page 8
Practice Code: C81008 | CHESTERFIELD, S45 9NR
Showing results 351-400 of 639
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Zuclopenthixol hydrochloride | 52 | 5,200 | £375 | +64.9% ▲ |
| Sodium bicarbonate | 52 | 7,700 | £380 | -43.7% ▼ |
| Insulin Lispro | 51 | 350 | £3.1K | -33.3% ▼ |
| Dexamethasone | 51 | 972 | £334 | -14.6% ▼ |
| Colestyramine | 50 | 3,159 | £883 | +73.6% ▲ |
| Atomoxetine hydrochloride | 50 | 2,224 | £3.9K | +47.9% ▲ |
| Roflumilast | 49 | 364 | £440 | +273.2% ▲ |
| 49 | 5,820 | £9.5K | +166.2% ▲ | |
| 49 | 3,017 | £260 | -1.8% vs avg | |
| Primidone | 48 | 5,168 | £6.2K | +34.9% ▲ |
| Norethisterone | 48 | 1,934 | £321 | -1.0% vs avg |
| 48 | 41.6K | £2.8K | +25.9% ▲ | |
| Guanfacine | 46 | 1,366 | £3.0K | +79.0% ▲ |
| Clobazam | 46 | 11.0K | £4.7K | -30.2% ▼ |
| Zonisamide | 46 | 4,256 | £1.9K | +5.4% ▲ |
| Hyoscine hydrobromide | 45 | 1,796 | £292 | +31.8% ▲ |
| Ibandronic acid | 45 | 1,487 | £1.4K | +23.8% ▲ |
| Miconazole nitrate | 45 | 1,570 | £250 | -36.4% ▼ |
| Salmeterol | 44 | 47 | £1.3K | +82.9% ▲ |
| Oxytetracycline | 44 | 3,416 | £1.3K | +70.3% ▲ |
| Tirzepatide | 44 | 44 | £4.1K | -77.3% ▼ |
| Metronidazole | 44 | 1,840 | £513 | +17.1% ▲ |
| 44 | 233 | £538 | +166.6% ▲ | |
| Medroxyprogesterone acetate | 43 | 2,174 | £458 | +12.4% ▲ |
| Triamcinolone acetonide | 43 | 45 | £62 | -42.5% ▼ |
| Brinzolamide and timolol | 43 | 250 | £387 | +13.8% ▲ |
| Hepatitis A | 43 | 43 | £782 | -43.4% ▼ |
| Powder preterm infant formula (0913111) | 42 | 119.2K | £1.9K | +163.7% ▲ |
| Azelaic acid | 42 | 1,260 | £197 | +75.7% ▲ |
| Other toiletry preparations | 42 | 11.4K | £227 | -1.7% vs avg |
| 42 | 114 | £474 | +35.4% ▲ | |
| Almotriptan | 41 | 342 | £745 | +230.8% ▲ |
| Powder thickener - starch based (0913161) | 41 | 9,180 | £258 | +185.4% ▲ |
| Typhoid | 41 | 41 | £424 | -54.5% ▼ |
| 41 | 464 | £936 | +4.2% ▲ | |
| 41 | 730 | £86 | +52.6% ▲ | |
| Sodium picosulfate | 40 | 11.1K | £986 | +10.2% ▲ |
| Ursodeoxycholic acid | 40 | 4,548 | £1.7K | -39.6% ▼ |
| Irbesartan | 40 | 1,750 | £77 | -83.6% ▼ |
| Bempedoic acid/Ezetimibe | 40 | 763 | £1.4K | -34.5% ▼ |
| Rizatriptan | 40 | 405 | £978 | -32.7% ▼ |
| Acetazolamide | 40 | 4,340 | £168 | +84.6% ▲ |
| Tacrolimus | 40 | 1,500 | £1.1K | -25.8% ▼ |
| 40 | 57 | £6.9K | +12.0% ▲ | |
| Prasugrel | 39 | 1,092 | £189 | +24.1% ▲ |
| 39 | 106 | £656 | +40.2% ▲ | |
| Brivaracetam | 38 | 2,128 | £4.9K | +11.7% ▲ |
| Colistimethate sodium | 38 | 2,108 | £4.4K | +236.1% ▲ |
| 38 | 4,200 | £1.1K | +39.2% ▲ | |
| Terbinafine hydrochloride | 37 | 1,750 | £588 | -40.1% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.